MTHFD1L-associated branched-chain amino acid degradation transcriptional signature represents a conserved metabolic program in Epstein-Barr virus-associated malignancies
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1955009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Jianmei Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, China. Hauptthemen laut MEDLINE: Amino Acids, Branched-Chain, Methylenetetrahydrofolate Dehydrogenase (NADP), Aminohydrolases, Herpesvirus 4, Human. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epstein-Barr virus (EBV)-associated malignancies encompass multiple tumor types with distinct tissue origins, yet the extent to which they share conserved metabolic programs remains poorly understood. Here, we performed an integrated cross-cancer transcriptomic analysis of nasopharyngeal carcinoma, EBV-associated gastric cancer, and EBV-associated plasmablastic lymphoma to identify conserved metabolic programs, followed by independent cohort validation and single-cell transcriptomic characterization. We identified 103 consensus differentially expressed genes and 72 conserved gene–metabolic pathway pairs across the three discovery cohorts. Among them, only the MTHFD1L—associated Valine, leucine and isoleucine degradation program was consistently preserved in both the discovery and validation cohorts. Single-cell analysis further demonstrated that this conserved metabolic program was predominantly enriched in CD4 + T cells, γδ T cells, and NK cells, and was accompanied by cell state-dependent metabolic remodeling, altered cell–cell communication, and distinct MTHFD1L-centered regulatory networks across immune cell populations. Collectively, our study identifies an MTHFD1L-associated branched-chain amino acid degradation transcriptional co-expression signature as a conserved metabolic program shared across EBV-associated malignancies and reveals its immune cell-specific and dynamic characteristics. These findings provide new insight into the metabolic adaptation of EBV-associated malignancies and offer a conceptual framework for the development of metabolism-targeted therapeutic strategies for virus-associated cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
- School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Department of Gastroenterology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Zitieren
APA
Zhou, J., Hao, H., Zhang, W., Mao, L., Zhao, X., & Zhu, J. (2026). MTHFD1L-associated branched-chain amino acid degradation transcriptional signature represents a conserved metabolic program in Epstein-Barr virus-associated malignancies. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1955009
Vancouver
Zhou J, Hao H, Zhang W, Mao L, Zhao X, Zhu J. MTHFD1L-associated branched-chain amino acid degradation transcriptional signature represents a conserved metabolic program in Epstein-Barr virus-associated malignancies. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1955009
BibTeX
@article{Zhou2026,
author = {Zhou, Jianmei and Hao, Hu and Zhang, Wenxia and Mao, Lin and Zhao, Xiaoran and Zhu, Jie},
title = {MTHFD1L-associated branched-chain amino acid degradation transcriptional signature represents a conserved metabolic program in Epstein-Barr virus-associated malignancies},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1955009}
}
EUVIMED